Cargando…
MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer
BACKGROUND: The latent involvement of MRPL13 in non-small cell lung cancer (NSCLC) remains unclear. This study aimed to explore the role of MRPL13 in NSCLC. METHODS: All analyses were performed in R software 4.0, SPSS version 23, and GraphPad Prism 8. The “limma” package was used to identify differe...
Autores principales: | Jing, Chuanqing, Fu, Rong, Wang, Can, Li, Xiurong, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285246/ https://www.ncbi.nlm.nih.gov/pubmed/34285575 http://dx.doi.org/10.2147/CMAR.S316428 |
Ejemplares similares
-
MRPL42 is activated by YY1 to promote lung adenocarcinoma progression
por: Jiang, Wei, et al.
Publicado: (2021) -
Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021) -
Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma
por: Zhong, Xugang, et al.
Publicado: (2023) -
MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
por: Hu, Yangyang, et al.
Publicado: (2023) -
MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway
por: Cai, Miaomiao, et al.
Publicado: (2021)